Early haemorrhagic morbidity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukaemia
Author:
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2000.01936.x/fullpdf
Reference25 articles.
1. American Association of Blood Banks 1996 Technical Manual 418
2. Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy;Asou;Journal of Clinical Oncology,1998
3. Tranexamic acid for control of haemorrhage in acute promyelocytic leukaemia;Avvisati;Lancet,1989
4. Idarubicin (4-demethoxydaunorubicin) as single agent for remission induction of previously untreated acute promyelocytic leukemia: a pilot study of the Italian cooperative group GIMEMA;Avvisati;European Journal of Haematology,1990
5. AIDA (All-trans retinoic acid+Idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study;Avvisati;Blood,1996
Cited by 116 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Distinctive features associated with differentiation syndrome in acute promyelocytic leukemia in patients treated by all-trans retinoic acid and arsenic trioxide;Leukemia Research;2024-10
2. Clinical characteristics and analysis of related factors associated with early death in newly diagnosed patients with acute promyelocytic leukemia;Discover Oncology;2024-08-27
3. Distinctive Features Associated with Differentiation Syndrome in Acute Promyelocytic Leukemia in Patients treated by All-Trans Retinoic Acid and Arsenic Trioxide;2024-04-26
4. Central venous catheters do not increase the hemorrhagic risk in acute promyelocytic leukemia patients during induction therapy;Frontiers in Oncology;2024-04-12
5. Leukemia Patients: A Retrospective Analysis of Outcomes and Healthcare Burden in US Hospitals;Turkish Journal of Hematology;2024-03-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3